Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures

被引:31
作者
Dirven, Linda [1 ]
Reijneveld, Jacob C. [1 ]
Aaronson, Neil K. [2 ]
Bottomley, Andrew [3 ]
Uitdehaag, Bernard M. J. [1 ,4 ]
Taphoorn, Martin J. B. [1 ,5 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[3] European Org Res Treatment Canc, Qual Life Dept, Brussels, Belgium
[4] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
[5] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands
关键词
Health-related quality of life; Brain tumors; Methodological limitations; Missing data; Response shift; Differential item functioning; Cognitive deterioration; CANCER CLINICAL-TRIALS; CELL LUNG-CANCER; RESPONSE SHIFT; SIGNIFICANT OTHERS; EORTC QLQ-C30; EUROPEAN-ORGANIZATION; METHODOLOGICAL ISSUES; FUNCTIONAL ASSESSMENT; CARE PROVIDERS; ADULT PATIENTS;
D O I
10.1007/s11910-013-0359-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Health-related quality of life (HRQOL) is a multidimensional concept used to measure patients' functioning and well-being. In recent decades, HRQOL has become an important (secondary) outcome measure in clinical trials for brain tumor patients. It could be questioned, however, whether HRQOL is the only useful outcome measure for assessing the level of functioning and well-being of these patients. As described in this review, several general methodological issues can hamper the interpretation of HRQOL data collected in the oncology setting. Additionally, because brain tumor patients have a progressive brain disease resulting in cognitive impairments, patient-reported outcomes may not always be the most informative and accurate measures of HRQOL in brain tumor patients. Supplementary or alternative measures, such as proxy-rated HRQOL measures and measures of instrumental activities of daily living, may provide a more complete picture of brain tumor patients' functioning in daily life.
引用
收藏
页数:9
相关论文
共 95 条
[1]
Aaronson N K, 1988, Oncology (Williston Park), V2, P69
[2]
Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma [J].
Aaronson, Neil K. ;
Taphoorn, Martin J. B. ;
Heimans, Jan J. ;
Postma, Tjeerd J. ;
Gundy, Chad M. ;
Beute, Guus N. ;
Slotman, Ben J. ;
Klein, Martin .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) :4430-4435
[3]
THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[4]
Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) [J].
Armstrong, T. S. ;
Mendoza, T. ;
Gring, I. ;
Coco, C. ;
Cohen, M. Z. ;
Eriksen, L. ;
Hsu, Ming-Ann ;
Gilbert, M. R. ;
Cleeland, C. .
JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (01) :27-+
[5]
Clinical Utility of the MDASI-BT in Patients with Brain Metastases [J].
Armstrong, Terri S. ;
Gning, Ibrahima ;
Mendoza, Tito R. ;
Weinberg, Jeffrey S. ;
Gilbert, Mark R. ;
Tortorice, Melissa L. ;
Cleeland, Charles S. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2009, 37 (03) :331-340
[6]
The FDA guidance for industry on PROs: the point of view of a pharmaceutical company [J].
Arpinelli, Fabio ;
Bamfi, Francesco .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[7]
Response shift: a brief overview and proposed research priorities [J].
Barclay-Goddard, Ruth ;
Epstein, Joshua D. ;
Mayo, Nancy E. .
QUALITY OF LIFE RESEARCH, 2009, 18 (03) :335-346
[8]
Primary brain tumours in adults [J].
Behin, A ;
Hoang-Xuan, K ;
Carpentier, AF ;
Delattre, JY .
LANCET, 2003, 361 (9354) :323-331
[9]
Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials [J].
Bottomley, A ;
Efficace, F ;
Thomas, R ;
Vanvoorden, V ;
Ahmedzai, SH .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2982-2992
[10]
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas - Comparison of patient and caregiver ratings of quality of life [J].
Brown, Paul D. ;
Decker, Paul A. ;
Rummans, Teresa A. ;
Clark, Matthew M. ;
Frost, Marlene H. ;
Ballman, Karla V. ;
Arusell, Robert M. ;
Buckner, Jan C. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02) :163-168